๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

103: Maternal and obstetric characteristics in women with stillbirth at a tertiary referral center

โœ Scribed by Brian Brocato; Rebecca Uhlmann; Ramasubbareddy Dhanireddy; Giancarlo Mari


Book ID
113436855
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
155 KB
Volume
204
Category
Article
ISSN
1097-6868

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Predictors of adalimumab dose escalation
โœ Russell D. Cohen; Jeffrey R. Lewis; Hannah Turner; Laura E. Harrell; Stephen B. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 167 KB ๐Ÿ‘ 2 views

Background: Pivotal trials for adalimumab (ADA) demonstrated effectiveness versus placebo for induction and maintenance of remission in moderate to severely active Crohn's disease (CD). Although the approved maintenance regimen in the U.S. is 40 mg subcutaneously every 14 days, some patients require